Vasopressin Receptor
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
CSN20586 | SR 49059 | 150375-75-0 | SR49059 is a potent and selective non-peptide vasopressin V1A receptor antagonist which is devoid of agonist activity SR49059 displays high affinity and efficacy at both rat Ki 16 nM and human Ki 11 - 63 nM V1A receptors and potently antagonizes arginine vasopressin-induced effects in vitro IC50 37 nM for inhibition of human platelet aggregation and is orally active in vivo |
CSN26793 | Mozavaptan hydrochloride | 138470-70-9 | Mozavaptan, also known as OPC 31260, is a vasopressin receptor antagonist marketed by Otsuka. In Japan, it was approved in October 2006 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH) due to ADH producing tumors. |
CSN21908 | Lixivaptan | 168079-32-1 | Lixivaptan is an orally active and selective vasopressin receptor V2 antagonist with IC50 values of 1.2 and 2.3 nM for human and rat V2, respectively. |
CSN13437 | Conivaptan hydrochloride | 168626-94-6 | Conivaptan HCl is an inhibitor of antidiuretic hormone or antagonist of vasopressin receptor. It can inhibit rat liver V1A receptor and kidney V2 receptor with Ki of 0.48 nM and 3.04 nM, respectively. |
CSN22355 | Balovaptan | 1228088-30-9 | Balovaptan is a highly potent and selective brain-penetrant vasopressin 1a (hV1a) receptor antagonist, with Kis of 1 and 39 nM for human (hV1a) and mouse (mV1a) receptors, and is used for the research of autism. |
CSN38255 | SRX246 | 512784-93-9 |